StockTipsArenaBeta

BUY Biocon Ltd — IDBI Capital

BUYBiocon Ltd
Biocon share price target & all analyst calls

byIDBI CapitalHorizon: 1–3 months23 Jun 2026via IDBI Capital Research Calls Telegram

Entry₹428Stated
Target₹463
Total upside +8.18% (call closed)
Stop loss₹412-3.74% risk
Exit₹41230 Jun 2026, 12:06 pm
Stop-loss hit-3.74%
Follow IDBI Capital for new calls(32% target hit, 190 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alertsSee 2 active Short-term calls on BIOCONSee 39 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 11:53 pm IST
3 supporting1 opposing
Supports the BUY call (3)

Biocon Ltd completed the acquisition of 1,15,36,956 equity shares of its material subsidiary, Biocon Biologics Limited (BBL), from 127 selling shareholders. In consideration, Biocon allotted 87,86,362

BSE · Company Update·29 Jun · today

(opens in new tab)

Biocon Limited has acquired an equity stake in Ampin C&I Power Twelve Private Limited, a Special Purpose Vehicle formed for generation and supply of solar power. This acquisition aligns with Biocon's

NSE · Acquisition·10 Jun · 3w ago

(opens in new tab)

3 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·20 May · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

2 advisors have active long-term SELL calls on this stock

Advisor consensus · adjacent horizon·14 Nov · 8mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from IDBI Capital

Every call and its outcome